Literature DB >> 17523778

Donepezil in vascular dementia : a neurosonological and neuropsychological study.

Cristina Paci1, Rocco Di Mascio, Roberto Gobbato, Terenzio Carboni, Sandro Sanguigni, Stefania Sobrini, Vittoria Urbano, Federico Olivieri, Luigi Curatola.   

Abstract

Entities:  

Year:  2005        PMID： 17523778     DOI： 10.2165/00044011-200525040-00007

Source DB:  PubMed          Journal:  Clin Drug Investig        ISSN： 1173-2563            Impact factor:   2.859


× No keyword cloud information.
  22 in total

1.  Rivastigmine in subcortical vascular dementia: a comparison trial on efficacy and tolerability for 12 months follow-up.

Authors:  R Moretti; P Torre; R M Antonello; G Cazzato
Journal:  Eur J Neurol       Date:  2001-07       Impact factor: 6.089

2.  Practice parameter: management of dementia (an evidence-based review). Report of the Quality Standards Subcommittee of the American Academy of Neurology.

Authors:  R S Doody; J C Stevens; C Beck; R M Dubinsky; J A Kaye; L Gwyther; R C Mohs; L J Thal; P J Whitehouse; S T DeKosky; J L Cummings
Journal:  Neurology       Date:  2001-05-08       Impact factor: 9.910

Review 3.  Donepezil for vascular cognitive impairment.

Authors:  R Malouf; J Birks
Journal:  Cochrane Database Syst Rev       Date:  2004

4.  Rivastigmine in subcortical vascular dementia: an open 22-month study.

Authors:  Rita Moretti; Paola Torre; Rodolfo M Antonello; Giuseppe Cazzato; Antonio Bava
Journal:  J Neurol Sci       Date:  2002-11-15       Impact factor: 3.181

Review 5.  The pharmacology of donepezil: a new treatment of Alzheimer's disease.

Authors:  D G Wilkinson
Journal:  Expert Opin Pharmacother       Date:  1999-11       Impact factor: 3.889

Review 6.  Donepezil: in vascular dementia.

Authors:  David R Goldsmith; Lesley J Scott
Journal:  Drugs Aging       Date:  2003       Impact factor: 3.923

7.  Donepezil in vascular dementia: a randomized, placebo-controlled study.

Authors:  D Wilkinson; R Doody; R Helme; K Taubman; J Mintzer; A Kertesz; R D Pratt
Journal:  Neurology       Date:  2003-08-26       Impact factor: 9.910

8.  The Global Deterioration Scale for assessment of primary degenerative dementia.

Authors:  B Reisberg; S H Ferris; M J de Leon; T Crook
Journal:  Am J Psychiatry       Date:  1982-09       Impact factor: 18.112

9.  Vascular dementia: diagnostic criteria for research studies. Report of the NINDS-AIREN International Workshop.

Authors:  G C Román; T K Tatemichi; T Erkinjuntti; J L Cummings; J C Masdeu; J H Garcia; L Amaducci; J M Orgogozo; A Brun; A Hofman
Journal:  Neurology       Date:  1993-02       Impact factor: 9.910

Review 10.  Cholinesterase inhibitors and vascular dementia: another string to their bow?

Authors:  Roger Bullock
Journal:  CNS Drugs       Date:  2004       Impact factor: 5.749
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.